NCT05578898Completed
CLEAR Care Companion Application
Source: ClinicalTrials.gov · Last updated 8 Jan 2025
Brief summary (registry, in English)
Hospital readmissions are common after major cancer surgery, leading to poorer patient outcomes, increased mortality and additional costs. In this study, Clinical and Engineering Approaches to Readmission (CLEAR) Care Companion Application, investigators aim to utilize a smartphone application that tracks concerning postoperative symptoms and provides educational interventions to determine if this can minimize delays in communication between patients and medical providers, increase patient satisfaction with the care received, and reduce or lessen the severity of readmissions.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 28 (actual)
- First submitted
- 10 Oct 2022
- Start date
- 12 Aug 2022
- Primary completion date
- 24 Jul 2024
- Lead sponsor
- University of Michigan Rogel Cancer Center
- Diseases
- Bladder cancer
- NCT number
- NCT05578898
What you commit to
- Study type: Interventional
- Participants enrolled: 28
- From 12 Aug 2022 to the primary completion date, 24 Jul 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Non-English speaking patients
- Patients without access to a smart phone or tablet with internet capacity
Who the study is looking for
- Patients undergoing a radical cystectomy with reconstruction through GU Oncology Clinic
- Patient at the University of Michigan (Michigan Medicine)
- Access to compatible smartphone or tablet device
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Michigan Rogel Cancer Center Coordinator of this site? Confirm its status | Ann Arbor | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.